SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-013979
Filing Date
2022-05-16
Accepted
2022-05-16 17:28:19
Documents
12
Period of Report
2022-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41216
2 ex10-1.htm EX-10.1 16060
  Complete submission text file 0001493152-22-013979.txt   226660

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgs-20220516.xsd EX-101.SCH 3147
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgs-20220516_lab.xml EX-101.LAB 35436
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgs-20220516_pre.xml EX-101.PRE 23130
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3569
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 22931176
SIC: 2834 Pharmaceutical Preparations